HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Carpenter, M. W. Articles by Star, J. A. Search for Related Content PubMed PubMed Citation Articles by Carpenter, M. W. Articles by Star, J. A. Social Bookmarking                What's this?

Amniotic Fluid Insulin at 14–20 Weeks’ Gestation

Association with later maternal glucose intolerance and birth macrosomia

¹ Obstetrics and Gynecology and
² Pathology
³ Center for Statistical Sciences, Brown University School of Medicine, Providence, Rhode Island
⁴ Beckman Instruments, Chaska, Minnesota

OBJECTIVE—To examine the hypothesis that early second trimester amniotic fluid (AF) insulin concentration is elevated and later fetal growth is augmented in gravidas demonstrating later oral glucose intolerance.

RESEARCH DESIGN AND METHODS—In this prospective observational cohort study, AF was sampled at 14–20 weeks’ gestation in 247 subjects, and 1-h 50-g oral glucose challenge tests (GCTs) were performed at 24 weeks. AF insulin was assayed by an automated immuno-chemiluminometric assay (8). Macrosomia was defined as birth weight above the 90th centile.

RESULTS—AF insulin concentration (range 1.4–44.5 pmol/l) correlated positively with gestational age and maternal weight. A logistic regression analysis, adjusted for maternal age and midpregnancy weight, showed increased AF insulin multiples of gestational age-specific medians to be associated with subsequently diagnosed gestational diabetes mellitus (GDM) (OR 1.9, CI 1.3–2.4, P = 0.029). Among 60 subjects with GCT values >7.2 mmol/l, each unit increase in AF insulin multiple of median (MOM) was associated with a threefold increase in fetal macrosomia incidence (3.1, 1.3–4.9, P = 0.048).

CONCLUSIONS—An elevated AF insulin concentration at 14–20 weeks’ gestation is associated with subsequently documented maternal glucose intolerance. Among gravidas with GCT values >7.2 mmol/l, elevated early AF insulin concentration is associated with fetal macrosomia. Maternal glucose intolerance may affect fetal insulin production before 20 weeks’ gestation.

Abbreviations: AF, amniotic fluid • GDM, gestational diabetes mellitus • MOM, multiple of median • GCT, glucose challenge test

CiteULike    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				S. L. Kjos and U. M. Schaefer-Graf Modified Therapy for Gestational Diabetes Using High-Risk and Low-Risk Fetal Abdominal Circumference Growth to Select Strict Versus Relaxed Maternal Glycemic Targets Diabetes Care, July 1, 2007; 30(Supplement_2): S200 - S205. [Full Text] [PDF]

				H. Leipold, C. Worda, A. Ozbal, P. Husslein, and E. Krampl First-Trimester Nuchal Translucency Screening in Pregnant Women Who Subsequently Developed Gestational Diabetes Reproductive Sciences, October 1, 2005; 12(7): 529 - 532. [Abstract] [PDF]